# Fractional Urate Excretion in Nonedematous Hyponatremia

> **NCT01425125** · NA · WITHDRAWN · sponsor: **NYU Langone Health**

## Conditions studied

- Cerebral Hyponatremia
- SIADH
- Cerebral Salt-wasting Syndrome
- Reset Hypothalamic Osmostat

## Interventions

- **DRUG:** Tolvaptan in euvolemic hyponatremia

## Key facts

- **NCT ID:** NCT01425125
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-11
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01425125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01425125, "Fractional Urate Excretion in Nonedematous Hyponatremia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01425125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*